According to the CDC 2015 Guidelines for the Treatment of Sexually Transmitted Diseases, what is a recommended treatment for women with condylomata acuminata during pregnancy?

The recommended treatment for women with condylomata acuminata (genital warts) during pregnancy is the application of trichloroacetic acid (TCA). This method is considered safe and effective for managing external genital warts in pregnant individuals. TCA works by chemically destroying the wart tissue, making it a practical choice since it poses a lower risk of systemic absorption and potential effects on the fetus.

Topical acyclovir is generally used for viral infections, primarily herpes simplex virus infections, but it is not effective for treating condylomata acuminata, which are caused by human papillomavirus (HPV). Laser therapy and electrosurgery are more invasive methods of treatment, typically reserved for larger or more extensive lesions outside of pregnancy, given the potential complications they may introduce during this sensitive period. Additionally, the safety of these procedures in pregnancy is not as well-established as that for trichloroacetic acid. Thus, the choice of TCA reflects a balanced approach that prioritizes safety for both the mother and the developing fetus while effectively treating the wart condition.